1.0400
-0.0700
(-6.31%)
At close: 4:00:00 PM EST
1.0415
+0.00
+(0.14%)
After hours: 6:36:50 PM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | -- | 0.00% | 0.00% |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | -0.2 | -0.2 | -0.18 | -0.11 |
EPS Actual | -0.16 | -0.35 | -0.02 | -0.11 |
Difference | 0.04 | -0.15 | 0.16 | 0 |
Surprise % | 20.00% | -70.73% | 88.89% | 0.00% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
NRSN | -- | -- | -- | -- |
S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
Downgrade | Maxim Group: Buy to Hold | 12/16/2024 |
Related Tickers
MEIP MEI Pharma, Inc.
2.7000
+1.50%
ADIL Adial Pharmaceuticals, Inc.
1.0200
-0.97%
XLO Xilio Therapeutics, Inc.
1.1000
-1.79%
ADAP Adaptimmune Therapeutics plc
0.6200
+0.02%
SCNI Scinai Immunotherapeutics Ltd.
3.5300
+1.44%
DRMA Dermata Therapeutics, Inc.
1.2000
-4.76%
ZVSA ZyVersa Therapeutics, Inc.
1.4700
+24.58%
ENTO Entero Therapeutics, Inc.
0.5899
-4.85%
ONVO Organovo Holdings, Inc.
0.4001
-7.92%
PXMD PaxMedica, Inc.
0.0650
-1.22%